Clinical Trial

Prospective Study of Detection of Sarcopenia in Clinical Practice for Patient With Ovarian or Endometrial Cancer

Study acronym: SARCO-GYN
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 3, 2023 (before its estimated October 2025 completion). Its status may not reflect the trial's current state.
Summary
Prospective monocentric study, non-randomized of the detection of sarcopenia in clinical practice in patients with ovarian or endometrial cancer requiring systemic oncological treatment. main question : Identify the criteria correlated with the presence of sarcopenia (defined by the measurement of the IMS by the CT-X method in L3) among the impedancemetry and the HAS malnutrition criteria. Data collection will be done at 6 months, 12 months after the date of inclusion.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-04-17; most recent amendment 2023-06-29.
Trial Details
NCT Number NCT05833321
Lead Sponsor Centre Hospitalier Metropole Savoie
Conditions Ovarian Neoplasms, Sarcopenia
Enrollment 75 participants
Start Date 2022-11-20
Primary Completion 2025-10 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2023-07-03